Compare DIS & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIS | JNJ |
|---|---|---|
| Founded | 1923 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.9B | 589.2B |
| IPO Year | 2018 | 2003 |
| Metric | DIS | JNJ |
|---|---|---|
| Price | $99.44 | $241.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 18 |
| Target Price | $134.73 | ★ $229.89 |
| AVG Volume (30 Days) | ★ 9.4M | 7.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 1.51% | ★ 2.15% |
| EPS Growth | ★ 151.84 | 90.50 |
| EPS | 1.34 | ★ 11.03 |
| Revenue | ★ $94,425,000,000.00 | N/A |
| Revenue This Year | $8.22 | $6.63 |
| Revenue Next Year | $4.27 | $7.23 |
| P/E Ratio | $74.28 | ★ $22.03 |
| Revenue Growth | ★ 3.35 | N/A |
| 52 Week Low | $80.10 | $141.50 |
| 52 Week High | $124.69 | $251.71 |
| Indicator | DIS | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 32.85 | 53.80 |
| Support Level | N/A | $235.43 |
| Resistance Level | $115.60 | $251.71 |
| Average True Range (ATR) | 1.95 | 4.11 |
| MACD | -0.32 | -1.41 |
| Stochastic Oscillator | 5.00 | 37.84 |
Disney operates in three global business segments: entertainment, sports, and experiences. Entertainment and experiences both benefit from the firm's ownership of iconic franchises and characters. Entertainment includes the ABC broadcast network, several cable television networks, and the Disney+ and Hulu streaming services. Within the segment, Disney also engages in movie and television production and distribution, with content licensed to movie theaters, other content providers, or, increasingly, kept in-house for use on Disney's own streaming platform and television networks. The sports segment houses the ESPN family of TV networks and streaming services. Experiences contains Disney's theme parks, cruises, and vacation destinations and also engages in merchandise licensing.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.